| RS1651768254 |
RNF2
|
Health Risk |
Pathogenic |
Luo-Schoch-Yamamoto syndrome, Luo-Schoch-Yamamoto syndrome |
| RS1651769432 |
FLG
|
Health Risk |
Likely pathogenic |
Dermatitis, atopic |
| RS1651811244 |
P3H1
|
Health Risk |
Pathogenic/Likely pathogenic |
Osteogenesis imperfecta type 8, Osteogenesis imperfecta type 8 |
| RS1651856824 |
MSH4
|
Health Risk |
Likely pathogenic |
Non-obstructive azoospermia, Non-obstructive azoospermia |
| RS1651872905 |
AGL
|
Health Risk |
Pathogenic/Likely pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS1651876607 |
LMNA
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary dilated cardiomyopathy, Cardiovascular phenotype |
| RS1651876879 |
AGL
|
Health Risk |
Pathogenic/Likely pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS1651877300 |
AGL
|
Health Risk |
Pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS1651879427 |
GJA8
|
Health Risk |
Pathogenic |
Cataract 1 multiple types, Cataract 1 multiple types |
| RS1651880905 |
AGL
|
Health Risk |
Pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS1651881222 |
GJA8
|
Health Risk |
Pathogenic |
Cataract 1 multiple types, Cataract 1 multiple types |
| RS1651881638 |
PHGDH
|
Health Risk |
Pathogenic |
PHGDH deficiency, PHGDH deficiency |
| RS1651881949 |
AGL
|
Health Risk |
Likely pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS1651883514 |
AGL
|
Health Risk |
Pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS1651887395 |
GJA8
|
Health Risk |
Conflicting classifications of pathogenicity |
Anterior segment dysgenesis, Cataract 1 multiple types |
| RS1651887603 |
GJA8
|
Health Risk |
Conflicting classifications of pathogenicity |
Anterior segment dysgenesis, Cataract 1 multiple types |
| RS1651890566 |
HSD3B2
|
Health Risk |
Pathogenic |
— |
| RS1651901764 |
HSD3B2
|
Health Risk |
Pathogenic |
— |
| RS1651905495 |
HSD3B2
|
Health Risk |
Likely pathogenic |
3 beta-Hydroxysteroid dehydrogenase deficiency, 3 beta-Hydroxysteroid dehydrogenase deficiency |
| RS1651907319 |
ATP1A2
|
Health Risk |
Likely pathogenic |
Migraine, familial hemiplegic |
| RS1651909230 |
HSD3B2
|
Health Risk |
Likely pathogenic |
— |
| RS1651911095 |
HSD3B2
|
Health Risk |
Likely pathogenic |
3 beta-Hydroxysteroid dehydrogenase deficiency, 3 beta-Hydroxysteroid dehydrogenase deficiency |
| RS1651918704 |
GJA8
|
Health Risk |
Conflicting classifications of pathogenicity |
Cataract 1 multiple types, Cataract 1 multiple types |
| RS1651919374 |
GJA8
|
Health Risk |
Pathogenic |
Cataract 1 multiple types, Cataract 1 multiple types |
| RS1651921400 |
FLG
|
Health Risk |
Pathogenic |
— |
| RS1651922528 |
ATP1A2
|
Health Risk |
Likely pathogenic |
— |
| RS1651922680 |
GJA8
|
Health Risk |
Conflicting classifications of pathogenicity |
GJA8-related disorder, GJA8-related disorder |
| RS1651940013 |
AGL
|
Health Risk |
Conflicting classifications of pathogenicity |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS1651940183 |
GJA8
|
Health Risk |
Conflicting classifications of pathogenicity |
Cataract 1 multiple types, Cataract 1 multiple types |
| RS1651944837 |
ATP1A2
|
Health Risk |
Pathogenic |
Familial hemiplegic migraine, Familial hemiplegic migraine |
| RS1651951474 |
AGL
|
Health Risk |
Likely pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS1651959213 |
ATP1A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Migraine, familial hemiplegic |
| RS1651972168 |
HS2ST1
|
Health Risk |
Pathogenic |
NEUROFACIOSKELETAL SYNDROME WITHOUT RENAL AGENESIS, NEUROFACIOSKELETAL SYNDROME WITHOUT RENAL AGENESIS |
| RS1651972956 |
ATP1A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Migraine, familial hemiplegic |
| RS1651973144 |
HS2ST1
|
Health Risk |
Pathogenic |
Neurofacioskeletal syndrome with or without renal agenesis, Neurofacioskeletal syndrome with or without renal agenesis |
| RS1651973884 |
ATP1A2
|
Health Risk |
Likely pathogenic |
— |
| RS1651974671 |
ATP1A2
|
Health Risk |
Likely pathogenic |
Migraine, familial hemiplegic |
| RS1651975273 |
ATP1A2
|
Health Risk |
Likely pathogenic |
— |
| RS1652001620 |
FLG
|
Health Risk |
Pathogenic |
— |
| RS1652003965 |
AGL
|
Health Risk |
Pathogenic/Likely pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS1652017784 |
AGL
|
Health Risk |
Pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS1652018859 |
AGL
|
Health Risk |
Pathogenic/Likely pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS1652044207 |
AGL
|
Health Risk |
Likely pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS1652081123 |
DRAM2
|
Health Risk |
Pathogenic |
— |
| RS1652094925 |
SPTA1
|
Health Risk |
Pathogenic |
SPTA1-related disorder, SPTA1-related disorder |
| RS1652115764 |
NPHP4
|
Health Risk |
Likely pathogenic |
Nephronophthisis, Nephronophthisis |
| RS1652116565 |
SZT2
|
Health Risk |
Pathogenic |
— |
| RS1652150288 |
PHGDH
|
Health Risk |
Pathogenic |
PHGDH deficiency, PHGDH deficiency |
| RS1652150709 |
FLG
|
Health Risk |
Pathogenic |
— |
| RS1652152909 |
P3H1
|
Health Risk |
Likely pathogenic |
Osteogenesis imperfecta type 8, Osteogenesis imperfecta type 8 |
| RS1652173183 |
SZT2
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 18 |
| RS1652224758 |
PHGDH
|
Health Risk |
Pathogenic |
PHGDH deficiency, PHGDH deficiency |
| RS1652267866 |
AGL
|
Health Risk |
Pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS1652268068 |
AGL
|
Health Risk |
Likely pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS1652276195 |
PHGDH
|
Health Risk |
Likely pathogenic |
PHGDH deficiency, Neu-Laxova syndrome 1 |
| RS1652276791 |
PHGDH
|
Health Risk |
Pathogenic |
PHGDH deficiency, PHGDH deficiency |
| RS1652293307 |
AGL
|
Health Risk |
Pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS1652306026 |
AGL
|
Health Risk |
Likely pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS1652311421 |
P3H1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type 8, Osteogenesis imperfecta type 8 |
| RS1652352034 |
P3H1
|
Health Risk |
Likely pathogenic |
Osteogenesis imperfecta type 8, Osteogenesis imperfecta type 8 |
| RS1652478579 |
HJV
|
Health Risk |
Pathogenic |
— |
| RS1652488301 |
HJV
|
Health Risk |
Pathogenic |
— |
| RS1652494092 |
HJV
|
Health Risk |
Conflicting classifications of pathogenicity |
Hemochromatosis type 2A, Hemochromatosis type 2A |
| RS1652495294 |
HJV
|
Health Risk |
Pathogenic/Likely pathogenic |
Hemochromatosis type 2A, Hemochromatosis type 2A |
| RS1652529952 |
WNT2B
|
Health Risk |
Conflicting classifications of pathogenicity |
Diarrhea 9, Diarrhea 9 |
| RS1652531375 |
SPTA1
|
Health Risk |
Pathogenic |
— |
| RS1652538079 |
HJV
|
Health Risk |
Pathogenic |
— |
| RS1652551021 |
P3H1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type 8, P3H1-related disorder |
| RS1652568567 |
HJV
|
Health Risk |
Pathogenic/Likely pathogenic |
Hemochromatosis type 2A, Hemochromatosis type 2A |
| RS1652577586 |
AGL
|
Health Risk |
Pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS1652583223 |
AGL
|
Health Risk |
Likely pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS1652590413 |
SPTA1
|
Health Risk |
Pathogenic |
Elliptocytosis 2, Elliptocytosis 2 |
| RS1652592444 |
HJV
|
Health Risk |
Pathogenic/Likely pathogenic |
Hemochromatosis type 2A, Hemochromatosis type 2A |
| RS1652593007 |
WNT2B
|
Health Risk |
Conflicting classifications of pathogenicity |
Diarrhea 9, Diarrhea 9 |
| RS1652673428 |
DARS2
|
Health Risk |
Likely pathogenic |
Leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome, Leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome |
| RS1652686086 |
FLG
|
Health Risk |
Likely pathogenic |
— |
| RS1652768821 |
P3H1
|
Health Risk |
Pathogenic/Likely pathogenic |
Osteogenesis imperfecta type 8, Osteogenesis imperfecta type 8 |
| RS1652784548 |
CFH
|
Health Risk |
Conflicting classifications of pathogenicity |
Atypical hemolytic-uremic syndrome, Atypical hemolytic-uremic syndrome |
| RS1652807016 |
HMGCS2
|
Health Risk |
Pathogenic/Likely pathogenic |
3-hydroxy-3-methylglutaryl-CoA synthase deficiency, 3-hydroxy-3-methylglutaryl-CoA synthase deficiency |
| RS1652848700 |
SPTA1
|
Health Risk |
Pathogenic |
— |
| RS1652849551 |
SPTA1
|
Health Risk |
Pathogenic |
— |
| RS1652870529 |
AGL
|
Health Risk |
Pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS1652875135 |
HMGCS2
|
Health Risk |
Likely pathogenic |
3-hydroxy-3-methylglutaryl-CoA synthase deficiency, 3-hydroxy-3-methylglutaryl-CoA synthase deficiency |
| RS1652877420 |
AGL
|
Health Risk |
Pathogenic/Likely pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS1652879873 |
AGL
|
Health Risk |
Pathogenic/Likely pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS1652885754 |
AGL
|
Health Risk |
Likely pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS1652885850 |
HMGCS2
|
Health Risk |
Pathogenic |
3-hydroxy-3-methylglutaryl-CoA synthase deficiency, 3-hydroxy-3-methylglutaryl-CoA synthase deficiency |
| RS1652887200 |
SZT2
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1652906180 |
AGL
|
Health Risk |
Pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS1652909202 |
AGL
|
Health Risk |
Pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS1652918497 |
MYOC
|
Health Risk |
Likely pathogenic |
Open-angle glaucoma, Open-angle glaucoma |
| RS1652924886 |
MYOC
|
Health Risk |
Likely pathogenic |
Open-angle glaucoma, Open-angle glaucoma |
| RS1652955748 |
HMGCS2
|
Health Risk |
Pathogenic |
3-hydroxy-3-methylglutaryl-CoA synthase deficiency, 3-hydroxy-3-methylglutaryl-CoA synthase deficiency |
| RS1652985519 |
AGL
|
Health Risk |
Pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS1652987369 |
CFH
|
Health Risk |
Pathogenic, low penetrance |
Atypical hemolytic-uremic syndrome, Atypical hemolytic-uremic syndrome |
| RS1652989506 |
CFH
|
Health Risk |
Pathogenic |
Atypical hemolytic-uremic syndrome, Atypical hemolytic-uremic syndrome |
| RS1653010161 |
P3H1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type 8, Osteogenesis imperfecta type 8 |
| RS1653042358 |
CFH
|
Health Risk |
Pathogenic, low penetrance |
Atypical hemolytic-uremic syndrome, Atypical hemolytic-uremic syndrome |
| RS1653045638 |
CFH
|
Health Risk |
Pathogenic |
— |
| RS1653132966 |
HMGCS2
|
Health Risk |
Likely pathogenic |
3-hydroxy-3-methylglutaryl-CoA synthase deficiency, 3-hydroxy-3-methylglutaryl-CoA synthase deficiency |